Summary Safety Review - DICLECTIN (doxylamine and pyridoxine combination) - Assessing Safety in pregnancy
Diclectin is a drug authorized in Canada to treat nausea and vomiting in pregnancy (i.e. morning sickness). The safety of Diclectin was recently reviewed by Health Canada as part of its routine health product monitoring. Public interest was also raised by recent media reports on Diclectin.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Similar records